JAMES JURA: Open Payments
NPI 1588698948 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,551 in 137 payments from 13 companies in 2025. Trend: 2023 $1,701 · 2024 $2,114 · 2025 $2,551
Food & beverage: $2,534Education: $16
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $332 |
| Neurocrine BioSciences, Inc. | 17 | $324 |
| E.R. Squibb & Sons, L.L.C. | 9 | $267 |
| Vanda Pharmaceuticals Inc. | 8 | $256 |
| ABBVIE INC. | 15 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $208 |
| Alkermes, Inc. | 8 | $196 |
| Teva Pharmaceuticals USA, Inc. | 13 | $173 |
| Lundbeck LLC | 7 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $146 |
Products named: INGREZZA, REXULTI, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII, FANAPT.
Industry payments across MO — which companies pay providers there.
